Please login to the form below

Not currently logged in
Email:
Password:

dermatology

This page shows the latest dermatology news and features for those working in and with pharma, biotech and healthcare.

The state of trust

The state of trust

Last year alone, 11, 000 papers were written on dermatology. How many HCPs have read even 110 of those? ”.

Latest news

More from news
Approximately 11 fully matching, plus 176 partially matching documents found.

Latest Intelligence

  • Pharma deals continue to slide Pharma deals continue to slide

    Roche has licensed a monoclonal antibody in phase II to Dermira, a dermatology company.

  • Deal Watch September 2016 Deal Watch September 2016

    The Vitae acquisition builds Allergan's dermatology pipeline with VTP-43742, a mid stage, orally active RORγt (retinoic acid receptor-related orphan receptor gamma) inhibitor for the potential treatment of psoriasis,

  • Deal Watch August 2016 Deal Watch August 2016

    So the product, which is an orphan drug, ended up in the portfolio of a $10bn company focussed on GI, dermatology and neurology and which was under investigation by the SEC

  • Deal Watch July 2016 Deal Watch July 2016

    Real Skin in the Game. Unusually there are several dermatology deals in July. ... Almirall is continuing to build the company's activities in dermatology, which now represents 43% of the company's revenues and is driving gross margin improvements.

  • Deal Watch May 2016 Deal Watch May 2016

    The pharmaceuticals company will include Novartis' other interests in CNS, ophthalmology, respiratory, cardiomet, immunology and dermatology.

More from intelligence
Approximately 0 fully matching, plus 33 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 23 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Adelphi Research UK

Adelphi Research UK is a healthcare insight partner. We uniquely blend robust market research with a consultancy approach, to guide...

Latest intelligence

Grabbing your audience*
Highlighting one of our recent pieces of work - a powerful disease awareness film created in partnership with Watchable Films...
Defining Market Access and the Key to Success
Kevin Lennon, Head of Operations & Market Access at OUTiCO, shares his definition of market access and the key to success....
the_other_side_of_multiple_sclerosis_thumb.jpg
THE OTHER SIDE OF … MULTIPLE SCLEROSIS
“My sister went without treatment despite relapses - enough was enough, I had to intervene”...

Infographics